Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Appropriate Use of Laxatives in the Older Person.

Pont LG, Fisher M, Williams K.

Drugs Aging. 2019 Sep 3. doi: 10.1007/s40266-019-00701-9. [Epub ahead of print]

PMID:
31478168
2.

Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.

Aldryhim AY, Alomair A, Alqhtani M, Mahmoud MA, Alshammari TM, Pont LG, Kamal KM, Aljadhey H, Mekonnen AB, Alwhaibi M, Balkhi B, Alhawassi TM.

Expert Opin Drug Saf. 2019 Aug;18(8):745-752. doi: 10.1080/14740338.2019.1632287. Epub 2019 Jul 11.

PMID:
31232612
3.

Defining constipation to estimate its prevalence in the community: results from a national survey.

Werth BL, Williams KA, Fisher MJ, Pont LG.

BMC Gastroenterol. 2019 May 21;19(1):75. doi: 10.1186/s12876-019-0994-0.

4.

Feasibility, acceptability and potential effectiveness of an information technology-based, pharmacist-led intervention to prevent an increase in anticholinergic and sedative load among older community-dwelling individuals.

van der Meer HG, Wouters H, Teichert M, Griens F, Pavlovic J, Pont LG, Taxis K.

Ther Adv Drug Saf. 2018 Oct 30;10:2042098618805881. doi: 10.1177/2042098618805881. eCollection 2019.

5.

Anticholinergic and sedative medication use in older community-dwelling people: A national population study in the Netherlands.

van der Meer HG, Taxis K, Teichert M, Griens F, Pont LG, Wouters H.

Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):315-321. doi: 10.1002/pds.4698. Epub 2019 Feb 12.

6.

Compliance with pathology testing guidelines in Australian general practice: protocol for a secondary analysis of electronic health record data.

Sezgin G, Georgiou A, Hardie RA, Li L, Pont LG, Badrick T, Franco GS, Westbrook JI, Rinehart N, McLeod A, Pearce C, Shearer M, Whyte R, Deveny E.

BMJ Open. 2018 Nov 13;8(11):e024223. doi: 10.1136/bmjopen-2018-024223.

7.

Prevalence, management and control of hypertension in older adults on admission to hospital.

Alhawassi TM, Krass I, Pont LG.

Saudi Pharm J. 2017 Dec;25(8):1201-1207. doi: 10.1016/j.jsps.2017.09.004. Epub 2017 Sep 14.

8.

Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial.

van der Meer HG, Wouters H, Pont LG, Taxis K.

BMJ Open. 2018 Jul 19;8(7):e019042. doi: 10.1136/bmjopen-2017-019042.

9.

Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: variation in polypharmacy and antipsychotic use.

Pont LG, Raban MZ, Jorgensen ML, Georgiou A, Westbrook JI.

Int J Qual Health Care. 2018 Dec 1;30(10):810-816. doi: 10.1093/intqhc/mzy098.

PMID:
29889231
10.

Changes in Prescribing Symptomatic and Preventive Medications in the Last Year of Life in Older Nursing Home Residents.

van der Meer HG, Taxis K, Pont LG.

Front Pharmacol. 2018 Jan 23;8:990. doi: 10.3389/fphar.2017.00990. eCollection 2017.

11.

Antihypertensive-related adverse drug reactions among older hospitalized adults.

Alhawassi TM, Krass I, Pont LG.

Int J Clin Pharm. 2018 Apr;40(2):428-435. doi: 10.1007/s11096-017-0583-7. Epub 2018 Feb 1.

PMID:
29392477
12.

Antidepressant switching patterns in the elderly.

Gadzhanova S, Roughead EE, Pont LG.

Int Psychogeriatr. 2018 Sep;30(9):1365-1374. doi: 10.1017/S1041610217002964. Epub 2018 Jan 30.

PMID:
29380718
13.

Automation bias in electronic prescribing.

Lyell D, Magrabi F, Raban MZ, Pont LG, Baysari MT, Day RO, Coiera E.

BMC Med Inform Decis Mak. 2017 Mar 16;17(1):28. doi: 10.1186/s12911-017-0425-5.

14.

Cross-national comparison of medication use in Australian and Dutch nursing homes.

Taxis K, Kochen S, Wouters H, Boersma F, Jan Gerard M, Mulder H, Pavlovic J, Stevens G, McLachlan A, Pont LG.

Age Ageing. 2018 Mar 1;47(2):319. doi: 10.1093/ageing/afx004. No abstract available.

PMID:
28087558
15.

Cross-national comparison of medication use in Australian and Dutch nursing homes.

Taxis K, Kochen S, Wouters H, Boersma F, Jan Gerard M, Mulder H, Pavlovic J, Stevens G, McLachlan A, Pont LG.

Age Ageing. 2017 Mar 1;46(2):320-323. doi: 10.1093/ageing/afw218. Erratum in: Age Ageing. 2017 Jan 13;:.

PMID:
27974305
16.

A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.

Beuscart JB, Pont LG, Thevelin S, Boland B, Dalleur O, Rutjes AWS, Westbrook JI, Spinewine A.

Br J Clin Pharmacol. 2017 May;83(5):942-952. doi: 10.1111/bcp.13197. Epub 2017 Jan 18. Review.

17.

Validity of prescribing indicators for assessing quality of antibiotic use in Australian general practice.

Pont LG, Morgan TK, Williamson M, Haaijer FM, van Driel ML.

Int J Pharm Pract. 2017 Feb;25(1):66-74. doi: 10.1111/ijpp.12318. Epub 2016 Oct 24.

PMID:
27774679
18.

Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older Persons.

Alhawassi TM, Krass I, Pont LG.

Drugs Real World Outcomes. 2015 Sep;2(3):239-247.

19.

Laxative Use and Self-Reported Constipation in a Community-Dwelling Elderly Population: A Community-Based Survey From Australia.

Werth BL, Williams KA, Pont LG.

Gastroenterol Nurs. 2017 Mar/Apr;40(2):134-141. doi: 10.1097/SGA.0000000000000144.

PMID:
27490279
20.

Does a Mobile Phone Depression-Screening App Motivate Mobile Phone Users With High Depressive Symptoms to Seek a Health Care Professional's Help?

BinDhim NF, Alanazi EM, Aljadhey H, Basyouni MH, Kowalski SR, Pont LG, Shaman AM, Trevena L, Alhawassi TM.

J Med Internet Res. 2016 Jun 27;18(6):e156. doi: 10.2196/jmir.5726.

21.

The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.

Shin HY, Gadzhanova S, Roughead EE, Ward MB, Pont LG.

Int Psychogeriatr. 2016 Jun;28(6):977-82. doi: 10.1017/S1041610215002434. Epub 2016 Jan 18.

PMID:
26775538
22.

Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review.

Alhawassi TM, Krass I, Pont LG.

J Pharm Policy Pract. 2015 Oct 14;8:24. doi: 10.1186/s40545-015-0042-6. eCollection 2015.

23.

Safety of opioid patch initiation in Australian residential aged care.

Gadzhanova S, Roughead EE, Pont LG.

Med J Aust. 2015 Oct 5;203(7):298.

PMID:
26424066
24.

Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures.

Pont LG, Nielen JT, McLachlan AJ, Gnjidic D, Chan L, Cumming RG, Taxis K.

Br J Clin Pharmacol. 2015 Nov;80(5):1169-75. doi: 10.1111/bcp.12670. Epub 2015 Jul 6.

25.

Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines.

Alhawassi TM, Krass I, Pont LG.

J Clin Hypertens (Greenwich). 2015 Jun;17(6):486-92. doi: 10.1111/jch.12536. Epub 2015 Mar 31. Review.

26.

A longitudinal study of constipation and laxative use in a community-dwelling elderly population.

Werth BL, Williams KA, Pont LG.

Arch Gerontol Geriatr. 2015 May-Jun;60(3):418-24. doi: 10.1016/j.archger.2015.02.004. Epub 2015 Feb 16.

PMID:
25736738
27.

A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.

Alhawassi TM, Krass I, Bajorek BV, Pont LG.

Clin Interv Aging. 2014 Dec 1;9:2079-86. doi: 10.2147/CIA.S71178. eCollection 2014. Review.

28.

Depression screening via a smartphone app: cross-country user characteristics and feasibility.

BinDhim NF, Shaman AM, Trevena L, Basyouni MH, Pont LG, Alhawassi TM.

J Am Med Inform Assoc. 2015 Jan;22(1):29-34. doi: 10.1136/amiajnl-2014-002840. Epub 2014 Oct 17.

29.
30.

Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.

Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4793-9. doi: 10.1128/AAC.00626-12. Epub 2012 Jul 2.

31.

Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines.

McLachlan AJ, Pont LG.

J Gerontol A Biol Sci Med Sci. 2012 Feb;67(2):175-80. doi: 10.1093/gerona/glr118. Epub 2011 Aug 10. Review.

PMID:
21835808
32.

Relationship between guideline treatment and health-related quality of life in asthma.

Pont LG, van der Molen T, Denig P, van der Werf GT, Haaijer-Ruskamp FM.

Eur Respir J. 2004 May;23(5):718-22.

33.

Validity of performance indicators for assessing prescribing quality: the case of asthma.

Pont LG, Denig P, van der Molen T, van der Veen WJ, Haaijer-Ruskamp FM.

Eur J Clin Pharmacol. 2004 Jan;59(11):833-40. Epub 2003 Nov 18.

PMID:
14624323
34.

Prescribing indicators for evaluating drug use in nursing homes.

van Dijk KN, Pont LG, de Vries CS, Franken M, Brouwers JR, de Jong-van den Berg LT.

Ann Pharmacother. 2003 Jul-Aug;37(7-8):1136-41.

PMID:
12841830
35.

Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000.

Pont LG, Sturkenboom MC, van Gilst WH, Denig P, Haaijer-Ruskamp FM.

Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):327-34.

PMID:
12812013
36.

The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice.

Pont LG, van Gilst WH, Lok DJ, Kragten HJ, Haaijer-Ruskamp FM; Dutch Working Group on Heart Failure.

Eur J Heart Fail. 2003 Mar;5(2):187-93.

37.

Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data.

Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM.

Eur J Clin Pharmacol. 2002 Jan;57(11):819-25.

PMID:
11871384
38.

Comparison of indicators assessing the quality of drug prescribing for asthma.

Veninga CC, Denig P, Pont LG, Haaijer-Ruskamp FM.

Health Serv Res. 2001 Apr;36(1 Pt 1):143-61.

Supplemental Content

Support Center